Alexis ARZIMANOGLOU (Lyon, France)
Miryam CARECCHIO (Padova, Italy)
Diane DOUMMAR (Paris, France)
Renzo GUERRINI (Firenze, Italy)
Philippe KAHANE (Grenoble, France)
Michael KRUER (Phoenix, USA)
Manju KURIAN (London, UK)
Vincenzo LEUZZI (Roma, Italy)
Jean-Pierre LIN (London, UK)
Jonathan MINK (Rochester, USA)
Nardo NARDOCCI (Milano, Italy)
Roser PONS (Athens, Greece)
Ingrid SCHEFFER (Melbourne, Australia)
Giovanna Zorzi (Milano, Italy)


Thursday, February 6th, 2020

Session 1: Background-1

10h00 – 10h30: Co-occurrence of movement disorders and epilepsy: an historical overview - Renzo Guerrini (Firenze, Italy)

10h30 – 11h00: The hunting of causative genes - Manju Kurian (London, UK)

11h00 – 11h30: Discussion

11h30 –12h00: Coffee Break


Session 2: Background-2

12h00 – 12h30: Basic cellular mechanisms involved in movement disorders and epilepsy Jonathan Mink (Rochester, USA)

12h30 – 13h: Pathways involved in the co-occurrence of movement disorders and epilepsyPhilippe Kahane (Grenoble, France)

13h – 13h30: Discussion

13h30 – 14h30: Lunch & Posters

14h30 – 15h30: Video session-1


Session 3: Clinical spectrum- 1

15h30 – 16h00: Disorders with fluctuations and/or paroxysmal dyskinesia- ADY5 and ATP1A3 related diseases

16h00 – 16h30: Complex hyperkinetic movement disorders as a core feature of GSMDE. ADCY5, GNAO1 and PDE10A related diseases - Miryam Carecchio (Padova, Italy)

16h30 – 17h00: Discussion

17h00 – 17h30: Coffee Break


Session 4: Clinical spectrum- 2

17h30 – 18h00: GSMDE with myoclonic epilepsy as main sign. TBC1D24 related diseasesRenzo Guerrini (Firenze, Italy) & P. Verstreken

18h00 – 18h45: Movement disorders associated with different genetic, developmental and epileptic encephalopathies. FOXG1 and STBT1 related diseasesIngrid Scheffer (Melbourne, Australia)

18h45 – 19h15: GSMDE due to loss- of-function mutations. FRRS1L and other genetic related diseases - Michael Kruer (Phoenix, USA)

19h15 – 19h45: Discussion

19h45 – 20h45: Video session-2


Friday, February 7th, 2020

Session 5 Clinical spectrum- 3

8h45 – 9h15: When the movement disorder is the dominant feature in GSMDEDiane Doummar (Paris, France)

11h15 – 11h45: When epilepsy is the dominant feature in GSMDE

11h45 – 12h15: Discussion

12h15 – 12h45: Coffee Break


Session 6: Clinical spectrum- 4

12h45 – 13h15: When neurodevelopmental deficit is in the frontline in GSMDEVincenzo Leuzzi (Rome, Italy)

13h15 – 13h45: GSMDE with parkinsonism as main sign - Roser Pons (Athens, Greece)

13h45 – 14h15: Lunch & Posters

15h15 – 16h15: Video session-3


Session 7: Therapeutics

16h15 – 16h45: Medical treatment of the epilepsy in GSMDE Alexis Arzimanoglou (Lyon, France)

16h45 – 17h15: Medical Treatment of the movement disorder - Giovanna Zorzi (Milano, Italy)

17h15 – 17h45: The place of deep brain stimulation in GSMDEJean-Pierre Lin (London, UK)

17h45 – 18h15: Innovative treatment perspectives

18h15 – 18h45: Discussion

18h45 – 19h45: Video session-4



Copyright © key4events - All rights reserved